MYONYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
MYOMO, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$1.25+0.05 (+4.17%)
Close on Oct 19, 2026
- Market cap
- $53.37M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.22 (+21.36%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
MYOMO, INC. grew revenue 6.1% to $43.26M over the twelve months to Jun 30, 2026. Free cash flow was -$8.32M.
Revenue
$43.26M
+6.1% vs. a year earlier
Operating income
-$11.70M
TTM Q2 2026
Free cash flow
-$8.32M
TTM Q2 2026
EPS, diluted
-$0.34
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $53.37M
- P/E ratio
- –
- Price to sales
- 1.23
- Price to book
- 9.16
- Dividend yield
- –
- Free cash flow yield
- -15.59%
Fundamentals
- Revenue
- $43.26M
- Net income
- -$14.51M
- EPS, diluted
- -$0.34
- Free cash flow
- -$8.32M
- Book value per share
- $0.14
- Diluted shares
- 43M
Eleven years at a glance
Fiscal years 2015 to 2025 and trailing twelve months, USD
Revenue
$43.26M+6.1% YoY
Gross profit
$29.57M+4.8% YoY
Operating income
-$11.70M
Net income
-$14.51M
EPS, diluted
-$0.34
Free cash flow
-$8.32M
Reported periodTrailing twelve months